BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 25548896)

  • 1. Oxidative stress in obesity: a critical component in human diseases.
    Marseglia L; Manti S; D'Angelo G; Nicotera A; Parisi E; Di Rosa G; Gitto E; Arrigo T
    Int J Mol Sci; 2014 Dec; 16(1):378-400. PubMed ID: 25548896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk of adipokines: a review.
    Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
    J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines as novel biomarkers and regulators of the metabolic syndrome.
    Deng Y; Scherer PE
    Ann N Y Acad Sci; 2010 Nov; 1212():E1-E19. PubMed ID: 21276002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organokines in disease.
    Chung HS; Choi KM
    Adv Clin Chem; 2020; 94():261-321. PubMed ID: 31952573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
    Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
    Hill JH; Solt C; Foster MT
    Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.
    Heyn GS; Corrêa LH; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():563816. PubMed ID: 33123088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue, obesity and adipokines: role in cancer promotion.
    Booth A; Magnuson A; Fouts J; Foster M
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines and obesity-linked disorders.
    Ouchi N; Ohashi K; Shibata R; Murohara T
    Nagoya J Med Sci; 2012 Feb; 74(1-2):19-30. PubMed ID: 22515108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).
    Varra FN; Varras M; Varra VK; Theodosis-Nobelos P
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review.
    Hamjane N; Benyahya F; Nourouti NG; Mechita MB; Barakat A
    Microvasc Res; 2020 Sep; 131():104023. PubMed ID: 32485192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.
    Lee MJ; Wu Y; Fried SK
    Mol Aspects Med; 2013 Feb; 34(1):1-11. PubMed ID: 23068073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokine dysregulation and adipose tissue inflammation in human obesity.
    Unamuno X; Gómez-Ambrosi J; Rodríguez A; Becerril S; Frühbeck G; Catalán V
    Eur J Clin Invest; 2018 Sep; 48(9):e12997. PubMed ID: 29995306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Metabolism in Obesity and Metabolic Syndrome.
    González-Domínguez Á; Visiedo-García FM; Domínguez-Riscart J; González-Domínguez R; Mateos RM; Lechuga-Sancho AM
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.